Literature DB >> 4301314

Specific role of each human leukocyte type in viral infections. II. Phytohemagglutinin-treated lymphocytes as host cells for vesicular stomatitis virus replication in vitro.

R Edelman, E F Wheelock.   

Abstract

The mitogenic agent, phytohemagglutinin (PHA), added to human mixed leukocyte cultures and to lymphocyte cultures converted small lymphocytes into lymphoblasts and increased lymphocyte susceptibility to vesicular stomatitis virus (VSV). Maximum virus yields were 30- to 1,000-fold higher in PHA-treated than in control cultures. VSV replicated to peak titers before lymphocytes were morphologically transformed by PHA, and virus titers fell as lymphoblast destruction began. PHA neither induced significant VSV replication in polymorphonuclear leukocyte cultures, nor increased the large virus yields in monocyte cultures. The treatment of PHA with heat, digestive enzymes, rabbit anti-PHA serum and serial dilutions failed to dissociate that portion of the PHA extract responsible for the conversion of lymphocytes into virus-susceptible cells from those components responsible for leukoagglutination or lymphocyte transformation.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4301314      PMCID: PMC375632     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  RNA SYNTHESIS IN CULTURES OF NORMAL HUMAN PERIPHERAL BLOOD.

Authors:  L B EPSTEIN; F STOHLMAN
Journal:  Blood       Date:  1964-07       Impact factor: 22.113

2.  SEPARATION OF LYMPHOCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES ON GLASS COLUMNS, INCLUDING TISSUE CULTURE OBSERVATIONS.

Authors:  Y RABINOWITZ
Journal:  Blood       Date:  1964-06       Impact factor: 22.113

3.  VIRAL LEUKOCYTE INTERRELATIONSHIPS. I. MULTIPLICATION OF A DNA VIRUS--HERPES SIMPLEX--IN HUMAN LEUKOCYTE CULTURES.

Authors:  A J JAHMIAS; S KIBRICK; R C ROSAN
Journal:  J Immunol       Date:  1964-07       Impact factor: 5.422

4.  IMMUNE RESPONSE AND MITOSIS OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO.

Authors:  K HIRSCHHORN; F BACH; R L KOLODNY; I L FIRSCHEIN; N HASHEM
Journal:  Science       Date:  1963-11-29       Impact factor: 47.728

5.  THE ACTION OF STREPTOLYSIN S ON PERIPHERAL LYMPHOCYTES OF NORMAL SUBJECTS AND PATIENTS WITH ACUTE RHEUMATIC FEVER.

Authors:  K HIRSCHHORN; R R SCHREIBMAN; S VERBO; R H GRUSKIN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-11       Impact factor: 11.205

6.  Induction of leucocyte growth in cultures of human peripheral blood.

Authors:  T PUNNETT; H H PUNNETT
Journal:  Nature       Date:  1963-06-22       Impact factor: 49.962

7.  Stimulation of Sendai virus multiplication by puromycin and actinomycin D.

Authors:  D O White; I M Cheyne
Journal:  Nature       Date:  1965-11-20       Impact factor: 49.962

8.  Enhancement of rhinovirus plaque formation in human heteroploid cell cultures by magnesium and calcium.

Authors:  M Fiala; G E Kenny
Journal:  J Bacteriol       Date:  1966-12       Impact factor: 3.490

9.  Replication of mumps virus in human leukocyte cultures.

Authors:  H Duc-Nguyen; W Henle
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

10.  Specific role of each human leukocyte type in viral infections. I. Monocyte as host cell for vesicular stomatitis virus replication in vitro.

Authors:  R Edelman; E F Wheelock
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

View more
  14 in total

1.  Replication of type I herpes simplex virus in primary cultures of hairy cell leukemic leukocytes.

Authors:  L H Pozner; C A Daniels; J A Cooper; H J Cohen; G L Logue; B P Croker
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

2.  Phytohemagglutinin activation of the transcription of the bovine leukemia virus genome requires de novo protein synthesis.

Authors:  R Chatterjee; P Gupta; S V Kashmiri; J F Ferrer
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

3.  Replication or inactivation of different viruses by human lymphocyte preparations.

Authors:  A M Denman; B Rager-Zisman; T C Merigan; D A Tyrrell
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

4.  Ultrastructural examination of phytohemagglutinin stimulated lymphocytes infected with vesicular stomatitis virus.

Authors:  G K McFadden; R L Truitt; I L Shechmeister
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  An interferon-like inhibitor of foot-and-mouth disease virus induced by phytohemagglutinin in swine leukocyte cultures.

Authors:  J Y Richmond
Journal:  Arch Gesamte Virusforsch       Date:  1969

6.  Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.

Authors:  K L Rosenthal; R M Zinkernagel; H Hengartner; P Groscurth; G Dennert; D Takayesu; L Prevec
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  Restricted replication of vesicular stomatitis virus in human lymphoblastoid cells.

Authors:  M Nowakowski; B R Bloom; E Ehrenfeld; D F Summers
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

8.  Isolation from mouse spleen of cell populations with high specific infectivity for scrapie virus.

Authors:  G C Lavelle; L Sturman; W J Hadlow
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

9.  In vitro assessment of cellular immunity to vaccinia virus: contribution of lymphocytes and macrophages.

Authors:  W A Tompkins; J M Zarling; W E Rawls
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

10.  Foot-and-mouth disease virus inhibition induced in mice by synthetic double-stranded RNA (polyriboinosinic and polyribocytidylic acids).

Authors:  J Y Richmond; L D Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.